title: The hemostatic efficacy of Ankaferd Blood Stopper in adenoidectomy.
abstract: OBJECTIVE
  To evaluate the efficacy of Ankaferd Blood Stopper (ABS) in the control of intraoperative and postoperative bleeding in adenoidectomy.
  
  
  METHODS
  In total, 90 patients underwent traditional cold steel adenoidectomy and were then randomized to receive ABS or 0.9% physiological saline solution to obtain hemostasis. Objective data collected included time of operation and blood loss during operation. Visual analog scales (VAS) were used to record subjective data by the operating surgeon including bleeding following adenoid pack removal and ease of operation.
  
  
  RESULTS
  In a comparison between patients in the ABS group (n = 46) and the control group (n = 44), those in the ABS group had significantly shorter operation times (9.11 ± 1.02 vs. 13.16 ± 3.96 min; p < 0.001) and less blood loss during the operation (20.19 ± 8.59 vs. 25.48 ± 12.96 ml; p ≤ 0.05) and a shorter hemostasis time (3.83 ± 0.8 vs. 5.82 ± 1.67 min; p < 0.001). Regarding hemorrhage after tampon removal, 40 patients (87%) in the ABS group and 17 patients (38.6%) in the control group did not suffer from hemorrhage (p < 0.001). Regarding ease of hemostasis, 40 patients (87%) in the ABS group experienced very easy or easy hemostasis while 26 patients in the control group did so (59.1%; p = 0.004). Patients in the ABS group returned to a regular diet earlier and had less use of analgesics at 7 days postoperatively. Use of electrocautery was less in the ABS group than in the control group (10.9 vs. 40.9%; p = 0.001).
  
  
  CONCLUSIONS
  The side on which ABS was used showed significant differences in hemostasis time, blood loss, and ease of hemostasis. ABS appears to be safe and effective; it decreases intraoperative bleeding and reduces operating time when compared to traditional hemostasis methods after curette adenoidectomy.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, Harran University, Hospital, 63300 Sanliurfa, Turkey. iiynen@hotmail.com
authors.forename: Ismail
authors.initials: I
authors.lastname: Iynen
authors.forename: Ferhat
authors.initials: F
authors.lastname: Bozkus
authors.forename: Imran
authors.initials: I
authors.lastname: San
authors.forename: Necat
authors.initials: N
authors.lastname: Alatas
mesh_terms: D000233:Adenoidectomy / Q000009:adverse effects*; D000293:Adolescent; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006488:Hemostasis, Surgical; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D015508:Nasal Obstruction / Q000601:surgery; D009304:Nasopharyngitis / Q000601:surgery; D010936:Plant Extracts / Q000627:therapeutic use*; D019106:Postoperative Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D020181:Sleep Apnea, Obstructive / Q000601:surgery
chemical_list: D006490:Hemostatics; D010936:Plant Extracts; C539751:ankaferd blood stopper